Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin
Sheila A DoggrellDepartment of Pharmacology, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, AustraliaA recent review by Panagoulias and Doupis, published in Patient Preference and Adherence, concerned the saxagliptin/metformin fixed combination...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-04-01
|
| Series: | Patient Preference and Adherence |
| Online Access: | http://www.dovepress.com/clinical-outcomes-not-clinical-utility-should-be-the-major-considerati-a16465 |